Weighted Average Number of Shares Outstanding, Diluted of NovoCure Ltd from 30 Sep 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NovoCure Ltd quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2018 to 31 Dec 2025.
  • NovoCure Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 111,471,991, a 3.4% increase year-over-year.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 111,471,991, a 3.4% increase from 2024.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 107,834,368, a 1.4% increase from 2023.
  • NovoCure Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 106,391,178, a 1.7% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

NovoCure Ltd Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 111,471,991 +3,637,623 +3.4% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 111,908,252 +3,660,536 +3.4% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 111,572,191 +3,871,907 +3.6% 01 Apr 2025 30 Jun 2025 10-Q 24 Jul 2025 2025 Q2
Q1 2025 110,281,832 +3,015,634 +2.8% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q4 2024 107,834,368 +1,443,190 +1.4% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 108,247,716 +1,474,902 +1.4% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 107,700,284 +1,411,211 +1.3% 01 Apr 2024 30 Jun 2024 10-Q 24 Jul 2025 2025 Q2
Q1 2024 107,266,198 +1,599,126 +1.5% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025 2025 Q1
Q4 2023 106,391,178 +1,364,233 +1.3% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 106,772,814 +1,888,231 +1.8% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024 2024 Q3
Q2 2023 106,289,073 +1,661,284 +1.6% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024 2024 Q2
Q1 2023 105,667,072 +1,480,952 +1.4% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 105,026,945 +1,142,657 +1.1% 01 Oct 2022 31 Dec 2022 10-K 23 Feb 2023 2022 FY
Q3 2022 104,884,583 +1,153,436 +1.1% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023 2023 Q3
Q2 2022 104,627,789 +1,142,923 +1.1% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023 2023 Q2
Q1 2022 104,186,120 +1,552,575 +1.5% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 103,884,288 -6,720,426 -6.1% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 103,731,147 -4,912,667 -4.5% 01 Jul 2021 30 Sep 2021 10-K 23 Feb 2023 2022 FY
Q2 2021 103,484,866 -4,162,936 -3.9% 01 Apr 2021 30 Jun 2021 10-K 23 Feb 2023 2022 FY
Q1 2021 102,633,545 -5,467,078 -5.1% 01 Jan 2021 31 Mar 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 110,604,714 +2,693,195 +2.5% 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 108,643,814 +1,039,236 +0.97% 01 Jul 2020 30 Sep 2020 10-K 23 Feb 2023 2022 FY
Q2 2020 107,647,802 +11,291,485 +12% 01 Apr 2020 30 Jun 2020 10-K 23 Feb 2023 2022 FY
Q1 2020 108,100,623 +13,289,341 +14% 01 Jan 2020 31 Mar 2020 10-K 23 Feb 2023 2022 FY
Q4 2019 107,911,519 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 107,604,578 +14,693,203 +16% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2022 2021 FY
Q2 2019 96,356,317 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2022 2021 FY
Q1 2019 94,811,282 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2022 2021 FY
Q3 2018 92,911,375 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3

NovoCure Ltd Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 111,471,991 +3,637,623 +3.4% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 107,834,368 +1,443,190 +1.4% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 106,391,178 +1,730,702 +1.7% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 104,660,476 +1,227,202 +1.2% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 103,433,274 -5,444,374 -5% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 108,877,648 +11,640,099 +12% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 97,237,549 +5,409,506 +5.9% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 91,828,043 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.